EFFECT OF DEOXYCYTIDINE ON 2-CHLORO-DEOXYADENOSINE-MEDIATED GROWTH-INHIBITION OF NORMAL HUMAN ERYTHROID AND MYELOID PROGENITOR CELLS

Citation
R. Bilgeri et al., EFFECT OF DEOXYCYTIDINE ON 2-CHLORO-DEOXYADENOSINE-MEDIATED GROWTH-INHIBITION OF NORMAL HUMAN ERYTHROID AND MYELOID PROGENITOR CELLS, Experimental hematology, 21(3), 1993, pp. 432-437
Citations number
24
Categorie Soggetti
Medicine, Research & Experimental",Hematology
Journal title
ISSN journal
0301472X
Volume
21
Issue
3
Year of publication
1993
Pages
432 - 437
Database
ISI
SICI code
0301-472X(1993)21:3<432:EODO2G>2.0.ZU;2-#
Abstract
The cytotoxic effect of chlorodeoxyadenosine (CdA) on lymphocytes and monocytes requires phosphorylation by the enzyme deoxycytidine kinase and can be antagonized by coadministration of deoxycytidine (dCyt), a competitive substrate of deoxycytidine kinase. It has also been shown for lymphocytes that coadministration of 3-aminobenzamide (3-ABA), an inhibitor of the enzyme poly-(ADP ribose) synthetase, is activated by CdA-mediated DNA strand breaks, consumes intracellular nicotinamide-di nucleotide (NAD) and can antagonize the lethal effect of CdA. Recent i n vitro studies have shown that not only growth of lymphocytes and mon ocytes, but also colony formation by erythroid and myeloid progenitors derived from normal human bone marrow, is inhibited by CdA in a dose- dependent manner. In this study we examined the effect of various dose s of dCyt (10(-6) to 10(-3) M) on CdA-mediated growth inhibition of er ythroid and myeloid progenitor cells in vitro. Our results show that c olony formation by human bone marrow-derived progenitor cells-CFU-E (c olony-forming unit erythroid), BFU-E (burst-forming unit erythroid) an d CFU-GM (colony-forming unit granulocyte/macrophage)-in semisolid med ium is protected by a high, but clinically achievable and nontoxic, co ncentration of dCyt (>10(-4) M) against the inhibitory effects of coad ministered high concentrations of CdA. The protective effect of dCyt w as markedly different on the various subclasses of progenitor cells, h owever. Thus, with coadministration of 10(-4) M dCyt, the CFU-E colony formation could be restored to almost 100% despite the presence of hi gh concentrations of CdA (160 nM) compared to control cultures, wherea s the colony formation of BFU-E and CFU-GM was restored to only 50%. A t a concentration of 10(-3) M dCyt, colony formation of BFU-E and CFU- GM was raised to 80% of control cultures even in the presence of high concentrations of CdA (160 nM). Further experiments in which 3-ABA was coadministered to CdA-treated cultures showed that in all concentrati ons tested (0.3 to 5 mM) 3-ABA was not able to prevent CdA-mediated cy totoxicity on bone marrow progenitors. Based on these studies, we sugg est that the CdA toxicity on CFU-E is mainly mediated by phosphorylati on by deoxycytidine kinase, whereas additional mechanisms may be opera tive in BFU-E and CFU-GM. Considerable biochemical differences seem to exist between hematopoietic stem cells on the one hand and lymphocyte s and monocytes from peripheral blood on the other.